Induction of IL-10 suppressors in lung transplant patients by CD4+25+ regulatory T cells through CTLA-4 signaling. 2006
alf: ctla-4 il-10

edit delete

Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression. 2006
alf: ctla-4 dc

edit delete

Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86. 2006
alf: cd28 cd80 cd86 ctla-4

edit delete

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. 2000
alf: ctla-4 tolerance

edit delete

Targeted CTLA-4 engagement induces CD4+CD25+CTLA-4high T regulatory cells with target (allo)antigen specificity. 2004
alf: ctla-4 specificity treg

edit delete

CTLA4Ig: bridging the basic immunology with clinical application. 2006
alf: ctla-4 treatment

edit delete

CTLA-4 up-regulation of lymphocyte function-associated antigen 1 adhesion and clustering as an alternate basis for coreceptor function. 2005
alf: ctla-4

edit delete

Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206. 2005
alf: ctla-4

edit delete

Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma. 2005
alf: ctla-4 treatment

edit delete

Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. 2005
alf: ctla-4 treatment

edit delete
older →